^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

JS108

i
Other names: JS108, DAC-002, recombinant humanized anti-Trop2 mAb-Tub196 conjugate
Associations
Trials
Company:
Hangzhou DAC Biotech, Shanghai Junshi Biosci
Drug class:
Microtubule inhibitor, TROP-2-targeted antibody-drug conjugate
Related drugs:
Associations
Trials